Alvotech has appointed a new chief quality officer in the wake of manufacturing deficiencies being identified by the US FDA. Meanwhile, multiple executives have departed from Hikma’s management team, with one joining Lupin as chief scientific officer.
Alvotech has announced the appointment of Sarah Tanksley as chief quality officer, with effect from today, 14 October. Tanksley succeeds Reem Malki, who is “stepping down for personal reasons,” according to the biosimilars specialist.
“Sarah has been actively working with Alvotech as a consultant and we are very pleased that she will join our...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
